Dominion Diagnostics Executive and Leadership Team

Robert Garvey, the Chief Executive Officer at Dominion Diagnostics, directs the company's overarching strategy and vision. Garvey guides the organization's expansion within the behavioral health, primary care, and hospital system sectors, ensuring the delivery of critical drug monitoring solutions and diagnostic testing services. This leadership role involves aligning departmental objectives with the company's mission to support healthcare providers in effective patient medication management. Garvey's strategic direction ensures Dominion Diagnostics maintains its position as a key provider of clinical information and support services, directly impacting patient outcomes through precise diagnostic insights. The Chief Executive Officer's focus remains on driving operational excellence and fostering innovation in laboratory services. Robert Garvey's executive oversight ensures the company's continued growth and commitment to advancing healthcare diagnostics.

Mark Peters, the Chief Financial Officer at Dominion Diagnostics, manages the company's financial operations and fiscal strategy. Peters oversees all aspects of financial planning, budgeting, and reporting, ensuring the fiscal health and stability of the organization. This role is critical in supporting the company's specialized drug monitoring solutions and diagnostic testing services, particularly in managing the financial implications of advanced laboratory operations. Peters works closely with other executive leaders to allocate resources effectively, driving growth and profitability within the healthcare sector. The Chief Financial Officer's responsibilities include optimizing financial performance and ensuring compliance with all relevant financial regulations. Mark Peters's financial acumen is essential for Dominion Diagnostics's continued success in providing comprehensive laboratory testing and clinical support to healthcare providers nationwide.

Dave Senerchia, the Chief Financial Officer & Executive VP, Business Development at Dominion Diagnostics, spearheads financial strategy and drives new business initiatives. Senerchia's dual role encompasses managing the company's financial health while simultaneously identifying and cultivating strategic growth opportunities within the diagnostic testing and medication management markets. This involves developing robust financial models to support expansion and overseeing the execution of business development plans that align with Dominion Diagnostics's core mission. Senerchia's leadership ensures that financial resources are effectively deployed to capitalize on market trends and enhance the company's service offerings to behavioral health, primary care, and hospital systems. The Executive VP, Business Development's focus is on expanding market reach and forging key partnerships. Dave Senerchia's comprehensive approach integrates financial prudence with aggressive market expansion, solidifying Dominion Diagnostics's industry presence.

Mark McSally, the Chief Operating Officer & General Counsel at Dominion Diagnostics, directs operational execution and oversees all legal affairs. McSally ensures the efficient and compliant delivery of the company's specialized drug monitoring solutions and diagnostic testing services, managing the day-to-day operations that support healthcare providers. This critical role involves maintaining the integrity of laboratory processes and ensuring adherence to stringent regulatory standards across all service areas, including behavioral health and hospital systems. McSally's legal expertise provides essential guidance on corporate governance, risk management, and contractual obligations, safeguarding the company's interests. The Chief Operating Officer's focus is on optimizing operational workflows and enhancing service delivery. Mark McSally's integrated leadership ensures seamless operations and robust legal compliance, reinforcing Dominion Diagnostics's commitment to providing reliable clinical information and support.